Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 7/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.50 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | LPL | P06858 | 1/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL8612056 | 0.97 | ACHE (0.50) | ACHETDP1APOBEC3AAPOBEC3GALDH1A1 | |
| Hydrochloric Acid SCHEMBL1508422 | 0.97 | ACHE (0.50) | ACHETDP1APOBEC3AAPOBEC3GALDH1A1 | |
| Water SCHEMBL11594553 | 0.97 | ACHE (0.50) | ACHETDP1APOBEC3AAPOBEC3GALDH1A1 | |
| Iodide SCHEMBL8506434 | 0.97 | APOBEC3A (0.55) | ACHETDP1APOBEC3AAPOBEC3GALDH1A1 | |
| SCHEMBL27385711 | 0.97 | ACHE (0.50) | ACHETDP1APOBEC3AAPOBEC3GALDH1A1 | |
| SCHEMBL13548402 | 0.91 | ACHE (0.44) | ACHETDP1APOBEC3AAPOBEC3GALDH1A1 | |
| SCHEMBL2489383 | 0.86 | APOBEC3A (0.62) | ACHEAPOBEC3AAPOBEC3GCA9 | |
| Hydrochloric Acid SCHEMBL6368015 | 0.82 | APOBEC3A (0.59) | ACHETDP1APOBEC3AAPOBEC3GALDH1A1 | |
| Iodide SCHEMBL6373433 | 0.82 | APOBEC3A (0.69) | ACHEAPOBEC3AAPOBEC3GCA9 | |
| SCHEMBL11129103 | 0.81 | ACHE (0.47) | ACHETDP1ALDH1A1CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1047692-B1 | METHODS OF SYNTHESIZING AND SCREENING INHIBITORS OF BACTERIAL NAD SYNTHETASE ENZYME, COMPOUNDS THEREOF AND METHODS OF TREATING BACTERIAL AND MICROBIAL INFECTIONS WITH THESE INHIBITORS | UAB RESEARCH FOUNDATION (US) | 2004-07-21 | — | — | EP | claimed |
| US-20040063758-A1 | INHIBITORS OF BACTERIAL NAD SYNTHETASE | BROUILLETTE WAYNE J (US) | 2004-04-01 | — | — | US | claimed |
| US-6673827-B1 | Methods of treating fungal infections with inhibitors of NAD synthetase enzyme | THE UAB RESEARCH FOUNDATION | 2004-01-06 | — | — | US | claimed |
| JP-2002509149-A | — | — | 2002-03-26 | — | — | JP | claimed |
| EP-1109805-A1 | INHIBITORS OF BACTERIAL NAD SYNTHETASE | The UAB Research Foundation (US) | 2001-06-27 | — | — | EP | claimed |
| EP-1047692-A1 | METHODS OF SYNTHESIZING AND SCREENING INHIBITORS OF BACTERIAL NAD SYNTHETASE ENZYME, COMPOUNDS THEREOF AND METHODS OF TREATING BACTERIAL AND MICROBIAL INFECTIONS WITH THESE INHIBITORS | THE UAB RESEARCH FOUNDATION (US) | 2000-11-02 | — | — | EP | claimed |
| WO-2000010996-A1 | INHIBITORS OF BACTERIAL NAD SYNTHETASE | THE UAB RESEARCH FOUNDATION (US) | 2000-03-02 | — | — | WO | claimed |
| WO-1999036422-A1 | METHODS OF SYNTHESIZING AND SCREENING INHIBITORS OF BACTERIAL NAD SYNTHETASE ENZYME, COMPOUNDS THEREOF, AND METHODS OF TREATING BACTERIAL AND MICROBIAL INFECTIONS WITH INHIBITORS OF BACTERIAL NAD SYNTHETASE ENZYME | THE UAB RESEARCH FOUNDATION (US) | 1999-07-22 | — | — | WO | claimed |
| US-20230183489-A1 | COLORING COMPOSITION, INK JET RECORDING METHOD, IMAGE RECORDED MATERIAL, AND COLORING AGENT COMPOUND | FUJIFILM CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| US-9889102-B2 | Sigma receptor ligands and methods of modulating cellular protein homeostasis using same | DREXEL UNIVERSITY (US) | 2018-02-13 | — | — | US | disclosed |
| US-20170196862-A2 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2017-07-13 | — | — | US | disclosed |
| US-9528017-B2 | Inkjet ink and inkjet recording device | RICOH COMPANY, LTD. (JP) | 2016-12-27 | — | — | US | disclosed |
| CN-105555780-A | Syk inhibitors | GILEAD SCIENCES INC | 2016-05-04 | — | — | CN | disclosed |
| US-20150252204-A1 | BLACK INK FOR INKJET RECORDING, INK CARTRIDGE, AND INKJET RECORDING DEVICE | RICOH COMPANY, LTD. (JP) | 2015-09-10 | — | — | US | disclosed |
| WO-2001000197-A2 | METHODS OF TREATING FUNGAL INFECTIONS WITH INHIBITORS OF NAD SYNTHETASE ENZYME | THE UAB RESEARCH FOUNDATION (US) | 2001-01-04 | — | — | WO | disclosed |
| WO-2000010996-A1 | INHIBITORS OF BACTERIAL NAD SYNTHETASE | THE UAB RESEARCH FOUNDATION (US) | 2000-03-02 | — | — | WO | disclosed |
| EP-0385778-B1 | Fuel oil compositions | EXXON CHEMICAL PATENTS INC (US) | 1996-12-11 | — | — | EP | disclosed |
| US-5348561-A | Quaternary ammonium stabilizers to prevent sedimentation and color formation during storage | EXXON CHEMICAL PATENTS INC. (US) | 1994-09-20 | — | — | US | disclosed |
| EP-0385778-A1 | Fuel oil compositions | EXXON CHEMICAL PATENTS INC. (US) | 1990-09-05 | — | — | EP | disclosed |
| US-4394315-A | HYPOHALITE OXIDATION OF HYDROQUINONES, QUATERNARY AMMONIUM PHASE TRANSFER CATALYST | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1983-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063758-A1 | INHIBITORS OF BACTERIAL NAD SYNTHETASE | COASY, NADK, NQO1 | ACHE 2884/4885TDP1 1719/4885APOBEC3A 1643/4885 |
| US-20170196862-A2 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SCNN1B, SLC26A4 | ACHE 4738/4885TDP1 4837/4885APOBEC3A 4870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.